Australian regulators are lagging global rivals on the use of software and artificial intelligence in medical products, leading to commercialisation problems that sends promising companies moving overseas.
Read more about Nick Therkelsen-Terry & Navid Toosi Saidy's conversation with Denham Sadler from InnovationAus.com HERE.
Yorumlar